Maria Luisa Bondi′

Title: Maria Luisa Bondi′: Innovator in Ocular Disease Treatment

Introduction

Maria Luisa Bondi′ is a notable inventor based in Trabia, Italy. She has made significant contributions to the field of ocular disease treatment through her innovative research and development of nanostructured formulations. Her work focuses on enhancing the delivery of active ingredients, particularly silibinin, for treating various ocular conditions.

Latest Patents

Maria Luisa Bondi′ holds a patent for "Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases." This patent describes formulations that incorporate silibinin or other active ingredients within lipid nanoparticle systems, specifically of the SLN and NLC type. These formulations are based on calixarenes and may possess mucoadhesive properties. They are designed for use in treating neurodegenerative ocular diseases, showcasing the versatility of calixarene compounds in delivering active ingredients characterized by low water solubility and low bioavailability.

Career Highlights

Maria Luisa Bondi′ is associated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where she continues to advance her research in nanotechnology and ocular treatments. Her innovative approach has positioned her as a key figure in the development of new therapeutic strategies for ocular diseases.

Collaborations

She collaborates with esteemed colleagues such as Patrizia Guarneri and Emanuela Fabiola Craparo, contributing to a dynamic research environment focused on cutting-edge solutions in ocular health.

Conclusion

Maria Luisa Bondi′ exemplifies the spirit of innovation in the field of ocular disease treatment. Her contributions through patented formulations are paving the way for new therapeutic options, ultimately improving patient outcomes.